Rapt Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Rapt Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapt Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapt Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $930k | 37k | 24.85 |
| 2023-09-30 | $562k | 34k | 16.62 |
| 2023-06-30 | $730k | 39k | 18.70 |
| 2023-03-31 | $702k | 38k | 18.35 |
| 2022-12-31 | $663k | 34k | 19.80 |
| 2022-09-30 | $463k | 19k | 24.00 |
| 2022-06-30 | $260k | 14k | 18.12 |
| 2022-03-31 | $281k | 13k | 22.04 |
| 2021-12-31 | $436k | 12k | 36.74 |
| 2021-09-30 | $364k | 12k | 31.67 |
| 2021-06-30 | $297k | 9.4k | 31.67 |
| 2021-03-31 | $232k | 11k | 22.15 |
| 2020-12-31 | $205k | 10k | 19.68 |